Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Recent Advances in the Treatment of Helicobacter pylori Infection.

Bergamaschi A, Magrini A, Pietroiusti A.

Recent Pat Antiinfect Drug Discov. 2007 Nov;2(3):197-205. Review.

PMID:
18221177
2.

Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.

Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.

Clin Ther. 2008 Mar;30(3):528-34. doi: 10.1016/j.clinthera.2008.03.009.

PMID:
18405790
3.

Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.

Pilotto A, Franceschi M, Rassu M, Leandro G, Bozzola L, Furlan F, Di Mario F.

Dig Liver Dis. 2000 Nov;32(8):667-72.

PMID:
11142574
4.

Guidelines in the medical treatment of Helicobacter pylori infection.

Dzieniszewski J, Jarosz M.

J Physiol Pharmacol. 2006 Sep;57 Suppl 3:143-54.

PMID:
17033112
5.

Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.

Uygun A, Kadayifçi A, Yeşilova Z, Savaş MC, Ateş Y, Karslioğlu Y, Ciğerim M, Bağci S, Dağalp K.

Turk J Gastroenterol. 2004 Dec;15(4):219-24.

6.

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

Blum AL, Talley NJ, O'Moráin C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberöd A, Theodórs A, Sundin M, Bolling-Sternevald E, Junghard O.

N Engl J Med. 1998 Dec 24;339(26):1875-81.

7.

Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.

Molina-Infante J, Pazos-Pacheco C, Vinagre-Rodriguez G, Perez-Gallardo B, Dueñas-Sadornil C, Hernandez-Alonso M, Gonzalez-Garcia G, Mateos-Rodriguez JM, Fernandez-Bermejo M, Gisbert JP.

Helicobacter. 2012 Aug;17(4):269-76. doi: 10.1111/j.1523-5378.2012.00947.x. Epub 2012 Mar 30.

PMID:
22759326
8.

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.

Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA; Second Asia-Pacific Conference.

J Gastroenterol Hepatol. 2009 Oct;24(10):1587-600. doi: 10.1111/j.1440-1746.2009.05982.x.

PMID:
19788600
9.

Treatment of Helicobacter pylori infection.

Cavallaro LG, Egan B, O'Morain C, Di Mario F.

Helicobacter. 2006 Oct;11 Suppl 1:36-9. Review.

PMID:
16925610
10.

Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.

Georgopoulos SD, Xirouchakis E, Martinez-Gonzalez B, Sgouras DN, Spiliadi C, Mentis AF, Laoudi F.

Helicobacter. 2013 Dec;18(6):459-67. doi: 10.1111/hel.12062. Epub 2013 May 29.

PMID:
23714140
11.

Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.

Sugimoto M, Uotani T, Sahara S, Ichikawa H, Yamade M, Sugimoto K, Furuta T.

Helicobacter. 2014 Aug;19(4):312-8. doi: 10.1111/hel.12128. Epub 2014 Apr 1.

PMID:
24690010
12.

The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.

Wheeldon TU, Granström M, Hoang TT, Phuncarg DC, Nilsson LE, Sörberg M.

Aliment Pharmacol Ther. 2004 Jun 15;19(12):1315-21.

13.

Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?

Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E.

Turk J Gastroenterol. 2005 Mar;16(1):29-33.

14.

Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication.

Uygun A, Kadayifci A, Yesilova Z, Ates Y, Safali M, Ilgan S, Bagci S, Dagalp K.

Indian J Gastroenterol. 2007 Jul-Aug;26(4):174-7.

PMID:
17986746
15.

Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.

Chang WL, Sheu BS, Cheng HC, Yang YJ, Yang HB, Wu JJ.

J Gastroenterol Hepatol. 2009 Jul;24(7):1230-5. doi: 10.1111/j.1440-1746.2009.05829.x. Epub 2009 May 19.

PMID:
19476562
16.

'Rescue' therapies for the management of Helicobacter pylori infection.

Di Mario F, Cavallaro LG, Scarpignato C.

Dig Dis. 2006;24(1-2):113-30. Review.

PMID:
16699270
17.

Bismuth-based therapies for the first step eradication of Helicobacter pylori.

Sezgin O, Altintaş E, Uçbilek E, Tataroğlu C.

Turk J Gastroenterol. 2006 Jun;17(2):90-3.

18.

Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.

Nguyen TV, Bengtsson C, Yin L, Nguyen GK, Hoang TT, Phung DC, Sörberg M, Granström M.

Helicobacter. 2012 Aug;17(4):319-25. doi: 10.1111/j.1523-5378.2012.00950.x. Epub 2012 Apr 20.

PMID:
22759333
19.

A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).

Marin AC, McNicholl AG, Gisbert JP.

Expert Opin Pharmacother. 2013 May;14(7):843-61. doi: 10.1517/14656566.2013.782286. Epub 2013 Mar 29. Review.

PMID:
23537368

Supplemental Content

Support Center